Press Releases Bausch Health Companies Inc. Toronto S.E.

Equities

BHC

CA0717341071

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 16:00:00 2025-07-17 EDT			5-day change	1st Jan Change
8.910 ^CAD	+0.91%		-1.98%	-23.32%

07-10	Bausch Health Names Steven Lee Chief Accounting Officer	MT
07-10	Bausch Health Appoints New Chief Accounting Officer	MT

Press Releases

Bausch Health : Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh “I Wish I Knew” Campaign to Educate People About Xifaxan® (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence	07-07	PU
Bausch Health : Partners with YUN to Bring Pioneering Microbiome Skincare to Poland (English)	06-23	PU
Bausch: Q1 Earnings Snapshot	04-30	AQ
Bausch Health : First-Quarter 2025 Earnings Presentation	04-30	PU
Bausch Health : Announces Launch of Solta Medical’s Fraxel FTX™	04-25	PU
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris	04-10	AQ
Bausch Health Announces Conditional Redemption of Senior Notes	03-24	AQ
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes	03-20	AQ
Bausch Health : Announces Launch of Syndication of New Senior Secured Credit Facilities	03-19	PU
Bausch Health : Fourth Quarter and Full Year 2024 Earnings Presentation	02-19	PU
Bausch: Q4 Earnings Snapshot	02-19	AQ
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference	02-17	AQ
Bausch Health Statement on Selection of XIFAXAN for Inflation Reduction Act's Medicare Negotiation Program	01-20	AQ
Bausch + Lomb exploring several options including a potential sale	12-12	AQ
Bausch Health Appoints New Chief Medical Officer and Head of R&D	12-03	AQ
Bausch: Q3 Earnings Snapshot	24-10-30	AQ
BAUSCH HEALTH : ANNOUNCES THIRD QUARTER 2024 RESULTS Form 8 K	24-10-30	PU
Bausch Health : Third-Quarter 2024 Earnings Presentation	24-10-30	PU
Bausch Health and Salix survey highlights urgent need for improved understanding of liver disease across healthcare provider disciplines as prevalence of cirrhosis rises	24-10-09	AQ
Bausch Health : 2023 Annual Report	24-10-01	PU
Investor Alert and Limitation Period: Canadian investors that purchased shares of Bausch Health Companies, Inc. listed on the Toronto Stock Exchange need to act	24-09-30	AQ
Fitch Maintains Bausch + Lomb's Ratings on Rating Watch Evolving	24-09-12	AQ
Fitch Affirms Bausch Health's IDR at 'CCC'	24-09-12	AQ
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners	24-08-14	AQ
Bausch Health Announces Second Quarter 2024 Results	24-08-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bausch Health Companies Inc. Toronto S.E.

Equities

BHC

CA0717341071

Pharmaceuticals

Press Releases

Filters